menu-icon
login-button

Argus and BF&M announce shareholder approval of combination

Argusweb

Hamilton, Bermuda (23 December 2024) — Argus Group Holdings Limited (“Argus”) (BSX: AGH) and BF&M Limited (“BF&M”) (BSX: BFM) announce today that, at their respective Special General Meetings held earlier today on 23 December 2024, their respective shareholders have voted overwhelmingly in favour of, in the case of Argus, the proposed amalgamation of Argus and Eleos Health Ltd., a wholly-owned subsidiary of BF&M, (the “Amalgamation”) and, in the case of BF&M, certain governance matters related thereto, previously announced on 28 June 2024.

Under the terms of the amalgamation agreement, receipt of approval from Argus shareholders of the Amalgamation, and receipt of approval from BF&M shareholders of certain governance matters related to the Amalgamation, were conditions to completion of the Amalgamation.

With these conditions now satisfied, the Amalgamation is expected to complete on 6 January 2025. Trading in BF&M's shares and Argus' shares will continue to be suspended pending closing of the Amalgamation.